June 2025

In a landmark development, Gilead Sciences announced today that the U.S. Food and Drug Administration has approved Yeztugo (lenacapavir), the first injectable pre-exposure prophylaxis (PrEP) for HIV prevention requiring just two doses per year.

Fresenius Kabi has issued an urgent nationwide recall of a specific lot of its Ivenix Large-Volume Pump (LVP) Blood Products Administration Sets, following the discovery of a manufacturing defect that could lead to serious or even fatal consequences.

Responsible for Formulation Development of Oral Liquid and Nasal Formulations. Responsible for conducting Formulation Development Trials and documenting the details in LNB.

The application should be filled in the given format. If the information or documents in the application are incomplete, the application will be considered ineligible.

Ph.D, MD, MS, MDS in Botany, Chemistry, Pharmacology or equivalent degree or having 3 years research, training and design and Development experience

Post Graduate Degree in Life Sciences, including the integrated PG degree, from the recognized university.

Graduate (B.Tech) / Post Graduate Degree (M.Sc / MTech) in professional course (Biostatistics, Biotechnology, Computer Sciences, Electronics, Life Sciences , and equivalent Fields.)

M.Sc. in life sciences with NET, DBT-JRF, GATE or equivalent exam cleared. Minimum 60% marks in Masters or equivalent degree.

Postgraduate degree in Public Health, Microbiology, Biochemistry, Biostatistics, Statistics with 3 years post-qualification experience.